Crohn's Disease Clinical Trial
Official title:
A Comparative Study of Capsule Endoscopy, Magnetic Resonance Imaging and Computer Tomography Scanning of the Small Bowel in Crohn's Disease
The aim of this study is to evaluate three diagnostic methods for assessing small bowel disease in patients with suspected or known Crohn's disease. All patients are examined with ileo-colonoscopy, capsule endoscopy, MRI and CT of the small bowel within 14 days. However, capsule endoscopy is not performed in patients with stenosis detected at ileo-colonoscopy, MRI and/or CT. All investigations are described in a similar pre-defined and standardized fashion and the radiologist and physician responsible for describing the findings at MRI, CT and capsule endoscopy are blinded to the findings at ileo-colonoscopy. The physician in charge of treatment receives a randomised result of either MRI, CT or capsule endoscopy. Thereafter patients are followed during 12 months to evaluate differences in clinical outcome depending on the randomized result. In combination with the diagnostic validity and inter-observer agreement of MRI, CT and capsule endoscopy we seek to establish the optimal diagnostic strategy in these two patient categories.
OVERALL AIM OF THE STUDY To evaluate three diagnostic methods for assessment of intestinal
disease in patients with suspected or newly diagnosed Crohn's disease and patients with
known Crohn's disease.
PARTICIPATING CENTRES
- Department of Medical Gastroenterology, Odense University Hospital, DK-5000 Odense C
- Department of Internal Medicine, section of Gastroenterology, Vejle Hospital, DK-7100
Vejle
- Department of Internal Medicine, section of Gastroenterology, Sydvestjysk Hospital,
DK-6700 Esbjerg
- Department of Internal Medicine, section of Gastroenterology, Svendborg Hospital,
DK-5700 Svendborg
- Department of Radiology, Vejle Hospital, DK-7100 Vejle
PROTOCOL A
A comparative study of capsule endoscopy, magnetic resonance imaging and computer tomography
scanning of the small bowel in patients with suspected or newly diagnosed Crohn's disease
Protocol procedures:
At inclusion all patients will have a standardised work-up including medical history,
physical examination, blood and faeces samples and ileo-colonoscopy. Within two weeks MRI
and CT scanning of the small intestine (on the same day and in randomised order) and
subsequently CE will be performed in all patients. All investigations are described in a
similar pre-defined and standardized fashion and the radiologist and physician responsible
for describing the findings at MRI, CT and CE are blinded to the findings at
ileo-colonoscopy and the other small bowel examinations. In the follow-up part of the study
the physician in charge of the patient will be randomised to receive the results of either
MRI, CT or CE.
Anticipated outcome:
The study is performed to improve evidence about what is the best primary investigation for
assessment of small intestinal involvement in patients with suspected Crohn's disease, to
evaluate if a combination of diagnostic modalities may improve our assessment of disease
burden for the individual patients, to study whether the initial diagnostic modalities
affect the handling of the patients and to study the interobserver variation of MRI and CT
scanning.
PROTOCOL B
A comparative study of magnetic resonance imaging, computer tomography scanning and capsule
endoscopy in patients with known Crohn's disease
Protocol procedures:
At inclusion all patients will undergo a standardised work-up including history, physical
examination, blood and faeces samples and ileo-colonoscopy. Within two weeks MRI, CT
scanning of the small intestine (on the same day in randomised order) and capsule endoscopy
will be performed in all patients. Capsule endoscopy will not be performed in patients with
small bowel stenosis confirmed at ileo-colonoscopy, MRI and/or CT. All three investigations
will be described in a similar predefined standardized fashion with the radiologist blinded
to the findings at ileo-colonoscopy. In the randomised part of the study the physician in
charge of the patient will be randomised to receive the result of either MRI, CT og capsule
endoscopy.
Anticipated outcome:
The best diagnostic method for evaluation of small intestinal involvement in patients with
known Crohn's disease may be different from patients suspected of Crohn's disease. Thus in
the current study we hope to provide evidence of whether MRI, CT scanning or capsule
endoscopy is the best diagnostic approach.
;
Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03815851 -
Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery
|
N/A | |
Not yet recruiting |
NCT06100289 -
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
|
Phase 3 | |
Completed |
NCT02883452 -
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
|
Phase 1 | |
Recruiting |
NCT04777656 -
Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.
|
Phase 3 | |
Terminated |
NCT03017014 -
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
|
||
Recruiting |
NCT06053424 -
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease
|
Phase 1 | |
Recruiting |
NCT05428345 -
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
|
||
Completed |
NCT02508012 -
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
|
N/A | |
Terminated |
NCT02882841 -
MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients
|
N/A | |
Not yet recruiting |
NCT02858557 -
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
|
N/A | |
Completed |
NCT03010787 -
A First Time in Human Study in Healthy Volunteers and Patients
|
Phase 1 | |
Completed |
NCT02542917 -
Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study
|
||
Terminated |
NCT02417974 -
Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)
|
Phase 2 | |
Active, not recruiting |
NCT02316678 -
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
|
N/A | |
Completed |
NCT02154425 -
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
|
Phase 1 | |
Completed |
NCT02265588 -
Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).
|
N/A | |
Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
Completed |
NCT02193048 -
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
|
||
Recruiting |
NCT02395354 -
Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease
|
N/A | |
Completed |
NCT01958827 -
A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease
|
Phase 3 |